Back to search

Article

Drug Repurposing of β-blocker Propranolol in Osteosarcoma: Preclinical Antitumor Efficacy Alone or in Combination with Chemotherapy.

2020-07-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Osteosarcoma is still associated with poor response to therapy and alarmingly elevated mortality rates, especially in developing countries, highlighting the urgent need of novel therapeutic strategies. Given that β-adrenergic receptor (β-AR) signaling regulates many cellular processes involved in the initiation and progression of cancer, multiple efforts have be...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d830b3ec-1cec-5be2-99f1-4622547f7514
DOI
10.21203/rs.3.rs-44912/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Drug Repurposing of β-blocker Propranolol in Osteosarcoma: Preclinical Antitumor Efficacy Alone or in Combination with Chemotherapy.DOI 10.21203/rs.3.rs-44912/v1
Select a neighboring publication to make it the new centre.